Orocalm Honing- En Sinaasappelsmaak (Benzydamine Hydrochloride)

Benzydamine hydrochloride works by inhibiting pro‑inflammatory cytokine release, stabilising mast cells and suppressing prostaglandin synthesis. It also has a local anaesthetic effect that dampens nerve impulse transmission, providing both anti‑inflammatory and analgesic actions when applied to the oral mucosa.

The dosage of Orocalm Honing- En Sinaasappelsmaak is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms and clinical judgement. No fixed regimen is provided here; the prescriber will specify the appropriate frequency and duration.

Safety data for benzydamine hydrochloride in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the treating physician in consultation with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other topical NSAIDs such as diclofenac mouthwash, benzydamine offers a combined anti‑inflammatory and local anaesthetic effect, leading to rapid pain relief. It is generally well tolerated and does not require systemic absorption, whereas some alternatives may have higher systemic exposure.

Store the lozenges at ambient temperature, below 25 °C, in the original blister pack. Protect them from moisture, direct sunlight and extreme heat. Keep out of reach of children and do not use after the expiry date printed on the packaging.

The product is an oral lozenge. The patient should place one lozenge in the mouth and allow it to dissolve slowly, avoiding chewing. It should not be swallowed whole and should not be taken with other oral medications at the same time to prevent dilution of its local effect.

Serious risks, although rare, include allergic reactions such as rash, itching, swelling or difficulty breathing, as well as severe oral ulceration and angioedema. Any signs of hypersensitivity or persistent ulcerative lesions should prompt immediate medical evaluation.

The lozenge should be avoided in individuals with known hypersensitivity to benzydamine hydrochloride or any excipients, in patients with severe oral ulcerations, and in children younger than six years unless specifically directed by a physician.